151 related articles for article (PubMed ID: 7082164)
1. Estrogen receptors in primary breast cancer.
Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
Gapinski PV; Donegan WL
Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
[TBL] [Abstract][Full Text] [Related]
5. Survival with breast cancer: the importance of estrogen receptor quantity.
Shek LL; Godolphin W
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):243-50. PubMed ID: 2702979
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
[TBL] [Abstract][Full Text] [Related]
7. Influence of estrogen receptors on survival and recurrence in patients with breast cancer without lymph node metastases.
Maki HS; Hoehn JL
Arch Surg; 1989 Mar; 124(3):377-80. PubMed ID: 2919970
[TBL] [Abstract][Full Text] [Related]
8. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
10. The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients.
Crowe JP; Gordon NH; Hubay CA; Pearson OH; Marshall JS; McGuire WL
Surgery; 1986 Oct; 100(4):599-605. PubMed ID: 3764686
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group.
Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M
Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194
[TBL] [Abstract][Full Text] [Related]
12. [Steroid hormone receptors and survival in breast cancer patients].
Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors and breast cancer.
Nicholson RI; Griffiths K; Blamey RW; Bishop HM; Haybittle JL
Environ Health Perspect; 1981 Apr; 38():143-6. PubMed ID: 7238443
[TBL] [Abstract][Full Text] [Related]
14. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
Iguchi C; Nio Y; Itakura M
J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
Williams MR; Todd JH; Ellis IO; Dowle CS; Haybittle JL; Elston CW; Nicholson RI; Griffiths K; Blamey RW
Br J Cancer; 1987 Jan; 55(1):67-73. PubMed ID: 3814477
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
[TBL] [Abstract][Full Text] [Related]
19. Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer.
Coradini D; Cappelletti V; Miodini P; Ronchi E; Scavone G; Di Fronzo G
Tumori; 1984 Apr; 70(2):165-8. PubMed ID: 6730015
[TBL] [Abstract][Full Text] [Related]
20. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
